TROG 17.03 (LARK)

Title

Liver Ablative Radiotherapy utilizing Kilovoltage intrafraction monitoring

Summary

This study aims to show that incorporating Kilovoltage Intrafraction monitoring (KIM) in to liver SABR improves: treatment accuracy, patient treatment outcomes, and treatment efficiency.

Participating Centres

Current participating centres

Accrual Target

Current Accrual

Current accrual graph (PDF)

Expected Date of Accrual Completion

March 2023

Trial chairperson

Dominique Lee, Princess Alexandra Hospital

Tim Wang, Crown Princess Mary Cancer Centre, Westmead

Trial contact

Annette Dempsey
Clinical Research Associate
Phone: +61 2 4014 3916
Email: LARK@trog.com.au

Primary Sponsor

University of Sydney

Trial resources for TROG members

LARK 17.03 member page

We are thankful to our 14,500 patients who have participated in our research. Please continue the generous support.

Tweets by @TROGfightcancer